allied
academies
Virology Research Journal
Volume 1 Issue 4
Vaccines World 2017
Notes:
Page 48
November 09-10, 2017 Vienna, Austria
21
st
World Congress and Exhibition on
VACCINES, VACCINATION & IMMUNIZATION
The immunization status of children of 1st
grade in elementary schools of city of Trikala,
Greece in 2016-17
Chrysoula Papachristou, Giouvri Aikaterini, Kafygioti Vasiliki, Kathiasi
Christina, Argyriou Agoritsa, Dalavira Christina, Daiilianis Christos
and
Lychou Anastasia
General Hospital of Trikala, Greece
T
he purpose of this survey was to assess the immunization
status of children in the 1st grade of elementary school
in Trikala city in Greece and to write down the percentage
of coverage of each vaccine that is included in the national
immunization program and also to record the vaccination
coverage and to compare it with previous records at national
and global level. The size of the sample was 667 students of
30 schools in the city of Trikala. Of the 667 students, 618
students participated (92.65% participation). Percentage of
vaccination DTP-Polio (Diphtheria-Tetanus-Pertussis-Polio)
is low at 84.30%. The full 2-dose MMR vaccination rates are
low, of 89.64%. Hepatitis B: vaccination coverage 98.06%;
Haemophilus type B: coverage rate is very high 99.51%
and Meningitis C: very high vaccination coverage rate. A
significant increase is recorded in relation to 2012 rates of
98.71% versus 15%. Pneumococcus: very high vaccination
coverage. A significant increase is recorded in relation to the
rates of 2012, 89.71% versus 4% chickenpox: high vaccination
coverage 92.88% hepatitis A: High vaccination coverage rate
92.56% Influenza: The vaccination rate is low, just 16.99%, as
according to the national vaccination program only children
of high risk are vaccinated. Meningococcus B: this much-
discussed vaccine is recorded at low rates, 16.34% as the cost
of the vaccine is high and not covered by the insurance funds.
Rotavirus: It is a restricted vaccine as it is strictly given at
certain times, so if it is not done in the first infancy, it is not
recommended to use it later. This in combination with the
partial insurance coverage does not favor broad vaccination.
papchrysa@hotmail.comVirol Res J 2017, 1:4